Amneal to Report Second Quarter 2025 Results on August 5, 2025
Amneal Pharmaceuticals (NASDAQ: AMRX), a global biopharmaceutical company, has scheduled its second quarter 2025 financial results announcement for Tuesday, August 5, 2025, before the market opens. The company will host an audio webcast at 8:30 a.m. ET to discuss the results.
Investors can access the webcast through Amneal's Investor Relations website at investors.amneal.com. For those joining via phone, the U.S. dial-in number is 1 (833) 470-1428 with access code 627786. A replay will be available after the call.
Amneal Pharmaceuticals (NASDAQ: AMRX), un'azienda biofarmaceutica globale, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per martedì 5 agosto 2025, prima dell'apertura del mercato. La società terrà una webcast audio alle 8:30 a.m. ET per discutere i risultati.
Gli investitori possono accedere alla webcast tramite il sito web delle Relazioni con gli Investitori di Amneal all'indirizzo investors.amneal.com. Per chi partecipa telefonicamente, il numero statunitense è 1 (833) 470-1428 con codice di accesso 627786. Una registrazione sarà disponibile dopo la chiamata.
Amneal Pharmaceuticals (NASDAQ: AMRX), una compañía biofarmacéutica global, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el martes 5 de agosto de 2025, antes de la apertura del mercado. La empresa realizará una transmisión de audio en vivo a las 8:30 a.m. ET para analizar los resultados.
Los inversores pueden acceder a la transmisión a través del sitio web de Relaciones con Inversores de Amneal en investors.amneal.com. Para quienes se unan por teléfono, el número de marcación en EE.UU. es 1 (833) 470-1428 con el código de acceso 627786. Una repetición estará disponible después de la llamada.
Amneal Pharmaceuticals (NASDAQ: AMRX)는 글로벌 바이오제약 회사로서 2025년 2분기 재무 실적 발표를 2025년 8월 5일 화요일 시장 개장 전으로 예정했습니다. 회사는 동부 시간 기준 오전 8시 30분에 실적 발표를 위한 오디오 웹캐스트를 진행할 예정입니다.
투자자들은 Amneal 투자자 관계 웹사이트 investors.amneal.com을 통해 웹캐스트에 접속할 수 있습니다. 전화로 참여하는 경우 미국 내 전화번호는 1 (833) 470-1428이며, 접속 코드 627786를 사용해야 합니다. 통화 후 다시 듣기 서비스도 제공됩니다.
Amneal Pharmaceuticals (NASDAQ : AMRX), une entreprise biopharmaceutique mondiale, a prévu d’annoncer ses résultats financiers du deuxième trimestre 2025 le mardi 5 août 2025, avant l’ouverture des marchés. La société organisera une webdiffusion audio à 8h30 ET pour discuter des résultats.
Les investisseurs peuvent accéder à la webdiffusion via le site Relations Investisseurs d’Amneal à l’adresse investors.amneal.com. Pour ceux qui participent par téléphone, le numéro d’accès aux États-Unis est le 1 (833) 470-1428 avec le code d’accès 627786. Une rediffusion sera disponible après l’appel.
Amneal Pharmaceuticals (NASDAQ: AMRX), ein globales biopharmazeutisches Unternehmen, hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für Dienstag, den 5. August 2025, vor Markteröffnung geplant. Das Unternehmen wird um 8:30 Uhr ET eine Audio-Webcast veranstalten, um die Ergebnisse zu besprechen.
Investoren können über die Investor-Relations-Website von Amneal unter investors.amneal.com auf den Webcast zugreifen. Für Telefonteilnehmer lautet die US-Einwahlnummer 1 (833) 470-1428 mit dem Zugangscode 627786. Eine Aufzeichnung wird nach dem Anruf verfügbar sein.
- None.
- None.
BRIDGEWATER, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its second quarter 2025 financial results on Tuesday, August 5, 2025, prior to market open. The Company will host an audio webcast at 8:30 a.m. ET.
The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com. Individuals may register for the webcast by clicking the link here. To access the call through a conference line, dial 1 (833) 470-1428 (in the U.S.) or for a list of toll-free international numbers, visit this here. The access code for the call is 627786. A replay of the conference call will be posted shortly after the call.
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global biopharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 pharmaceuticals, primarily within the United States. In its Affordable Medicines segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com and follow us on LinkedIn.
Investor Contact
Anthony DiMeo
VP, Investor Relations
anthony.dimeo@amneal.com
Media Contact
Brandon Skop
Sr. Director, Corporate Communications
Brandon.skop@amneal.com
FAQ
When will Amneal Pharmaceuticals (AMRX) report Q2 2025 earnings?
How can investors access Amneal's Q2 2025 earnings call?
What time is Amneal's Q2 2025 earnings call?
Will there be a replay available of Amneal's Q2 2025 earnings call?
